NASDAQ : BRKR
Bruker Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 62 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.45B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 8.70B |
| Enterprise Value | 10.37B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Sep 21, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 152.36M |
| Shares Outstanding | 152.36M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 31.89% |
| Owned by Institutions (%) | 94.91% |
| Float | 103.69M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 25.46 |
| PS Ratio | 2.48 |
| Forward PS | 2.41 |
| PB Ratio | 3.65 |
| P/TBV Ratio | 103.76 |
| P/FCF Ratio | 92.60 |
| P/OCF Ratio | 45.67 |
| PEG Ratio | 1.65 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.96 |
| EV / EBITDA | 19.16 |
| EV / EBIT | 33.33 |
| EV / FCF | 110.39 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.85 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 3.10 |
| Debt / FCF | 19.76 |
| Interest Coverage | 5.06 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -3.00% |
| Return on Assets (ROA) | 3.14% |
| Return on Invested Capital (ROIC) | 7.60% |
| Return on Capital Employed (ROCE) | 6.41% |
| Weighted Average Cost of Capital (WACC) | 9.51% |
| Revenue Per Employee | $315,706 |
| Profits Per Employee | -$9,644 |
| Employee Count | 11,085 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.54 |
Taxes
| Measure | Value |
|---|
| Income Tax | 40.40M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +51.22% |
| 50-Day Moving Average | 58.90 |
| 200-Day Moving Average | 50.22 |
| Relative Strength Index (RSI) | 45.54 |
| Average Volume (20 Days) | 2,188,265 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 12.67M |
| Short Previous Month | 12.41M |
| Short % of Shares Out | 8.32% |
| Short % of Float | 12.22% |
| Short Ratio (days to cover) | 5.27 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.50B |
| Gross Profit | 1.70B |
| Operating Income | 311.00M |
| Pretax Income | -24.10M |
| Net Income | -106.90M |
| EBITDA | 541.10M |
| EBIT | 311.00M |
| Loss Per Share | -$0.70 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 184.90M |
| Total Debt | 1.86B |
| Net Cash | -1.67B |
| Net Cash Per Share | -$10.96 |
| Equity (Book Value) | 2.44B |
| Book Value Per Share | 15.63 |
| Working Capital | 1.02B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 190.40M |
| Capital Expenditures | -96.50M |
| Depreciation & Amortization | 230.10M |
| Net Borrowing | -574.60M |
| Free Cash Flow | 93.90M |
| FCF Per Share | $0.62 |
Margins
| Measure | Value |
|---|
| Gross Margin | 48.48% |
| Operating Margin | 8.89% |
| Pretax Margin | -0.69% |
| Profit Margin | -2.03% |
| EBITDA Margin | 15.46% |
| EBIT Margin | 8.89% |
| FCF Margin | 2.68% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $0.20 |
| Dividend Yield | 0.35% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | 32.45% |
| Buyback Yield | -0.13% |
| Shareholder Yield | 0.22% |
| Earnings Yield | -1.23% |
| FCF Yield | 1.08% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $63.83 |
| Price Target Difference | 11.85% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 4.46% |
| EPS Growth Forecast (3Y) | 14.99% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.53 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |